Patents Assigned to MEMORIAL SLOAN-KETTERING CANCER CENTER ("MSKCC")
  • Publication number: 20120252883
    Abstract: Disclosed herein are methods and compositions for treating cancer by increasing radiation-induced damage to cancer without increasing radiation-induced side effects by increasing secretory ASMase levels specifically in tumor endothelium, and inducing apoptosis of tumor endothelial cells by treating the tumor with radiation. ASMase levels are increased in tumor endothelium by administration of a recombinant DNA construct comprising a region coding for a functional ASMase linked to particular transcriptional regulatory sequences that confer tissue-specific expression of ASMase.
    Type: Application
    Filed: December 7, 2010
    Publication date: October 4, 2012
    Applicants: MEMORIAL SLOAN-KETTERING CANCER CENTER ("MSKCC")
    Inventors: Richard N. Kolesnick, Branka Stancevic, Michel Sadelain, Zvi Fuks, Nira Varda-Bloom, Dror Harats